Dr Peggy A Norton, MD | |
30 N 1900 E Rm 2b200, Salt Lake City, UT 84132-0002 | |
(801) 581-3565 | |
(801) 587-8431 |
Full Name | Dr Peggy A Norton |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 30 N 1900 E Rm 2b200, Salt Lake City, Utah |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063502672 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 178263-1205 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Peggy A Norton, MD 30 N 1900 E Rm 2b200, Salt Lake City, UT 84132-0002 Ph: (801) 581-3565 | Dr Peggy A Norton, MD 30 N 1900 E Rm 2b200, Salt Lake City, UT 84132-0002 Ph: (801) 581-3565 |
News Archive
PowerVision, Inc., a medical device company developing the world's first fluid-based accommodating intraocular lens, today announced that the first 10 patients have received lens implants in its multi-center clinical study assessing the performance of the lens in cataract patients.
CPM Marketing Group, Inc., the market leader for healthcare customer relationship management (CRM) and strategic marketing solutions, announced today the introduction of its Planning and Forecasting (P&F) system designed to provide actionable forecasting information to assist hospitals and health systems in planning.
Exhaustion syndrome, also called burnout and exhaustion depression, leaves objectively measurable changes in the brain including reduced activity in the frontal lobes and altered regulation of the stress hormone cortisol. This is shown in a new dissertation from Umeå University in Sweden.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.
› Verified 4 days ago
Virginia Jean Homewood, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3336 S 4155 W, Ste 301, Salt Lake City, UT 84120 Phone: 801-964-3865 Fax: 801-964-3894 | |
Alexandra L. Woodcock, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2a200, Salt Lake City, UT 84132 Phone: 801-213-3716 | |
Lillian B. Boettcher, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2b200, Salt Lake City, UT 84132 Phone: 801-581-7647 | |
Patricia Bearnson, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4465 S 900 E Ste 275, Salt Lake City, UT 84124 Phone: 801-272-6100 Fax: 801-272-6101 | |
Eric C Nielson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1220 East 3900 South, Suite 3e, Salt Lake City, UT 84124 Phone: 801-685-7188 Fax: 801-685-8116 | |
Susan T Horvath, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1140 E 3900 S Ste 400, Salt Lake City, UT 84124 Phone: 801-262-8666 Fax: 801-263-8821 | |
Carolyn Weaver Swenson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-213-2995 |